• Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

Femtech Trendwatch: Investment Round-up October, Male Contraceptives on the Rise & The Hims Story

By Femtech Insider Trend Watch, Uncategorized November 1, 2021
ShareTwitterFacebookPinterest-circled
  • Latest News
    • Menstrual Health
    • Reproductive Health
    • Fertility
    • Pregnancy
    • Maternal Health
    • Menopause
    • Hormonal Health
    • Mental Health
    • Gynecological Health
    • Endometriosis
    • Chronic Conditions
    • Sexual Wellness
    • Heart Disease
    • Pelvic Health
    • Bone Health
    • Cancer
  • Newsletter
  • Become a Member
  • Jobs
  • Events

To continue reading…

Become a premium member and get unlimited access to articles, weekly analysis, free access to out webinars and more:

Subscribe

Already a subscriber? Log in here.

You May Also Like

News, Trend Watch June 29, 2022
Femtech Trendwatch: Roe’s Final Hours, Innovation meets Health Equity & Startup Spotlight
Biotech, Gynecological Health, News, Pharma, Uncategorized, Women's Health June 8, 2021
Auransa and POLARISqb Enter Research Collaboration to Find Treatments for Neglected Women’s Diseases Like Endometriosis and PCOS
Recent Posts
  • Inne Receives UK and European Approval for Novel Saliva-Based Contraception Method
  • What’s New in Femtech This Week? (June 19, 2025)
  • Maven Clinic Partners with ŌURA to Integrate Biometric Data into Women’s Health Care
  • Hera Biotech Acquires Point-of-Care Cervical Cancer Diagnostic HeraFem
  • Metabolic Health Company Veracity Raises $6M

About Femtech Insider

Advertise with us!

Become a Member!

Contact us

Privacy Policy // Terms of Use

Femtech Insider Ltd. © 2025. All rights reserved.